One Wealth Advisors LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,272 shares of the company’s stock, valued at approximately $594,000.
Several other hedge funds also recently bought and sold shares of the company. Cerity Partners LLC grew its stake in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after buying an additional 5,092 shares in the last quarter. National Pension Service grew its stake in shares of HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after buying an additional 17,531 shares in the last quarter. Savant Capital LLC grew its stake in shares of HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after buying an additional 1,246 shares in the last quarter. Sector Gamma AS boosted its holdings in HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after purchasing an additional 108,849 shares during the period. Institutional investors own 62.73% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently issued reports on HCA. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday. JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a report on Friday, February 20th. Stephens decreased their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Argus lifted their price target on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Finally, Barclays decreased their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $520.55.
HCA Healthcare Stock Down 0.2%
Shares of HCA stock opened at $433.73 on Friday. The stock has a market capitalization of $96.50 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.38 and a beta of 1.19. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The stock’s 50-day moving average price is $497.66 and its 200 day moving average price is $485.41.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is 10.73%.
Insiders Place Their Bets
In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. Company insiders own 1.50% of the company’s stock.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
